North America Hematology Analyzers and Reagents Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : North America Hematology Analyzers and Reagents Market

Data Bridge Market Research analyses that the North America hematology analyzers and reagents market to be grow at a CAGR of 5.90% in the forecast period of 2021-2028.

Hematology is a branch of medicine concerned with the study, diagnosis, and treatment of blood problems. Lymphoma, bone marrow, white blood cells, platelets, and red blood cells are all treated appropriately. Hematology also deals with the plasma, which is the liquid component of the blood. Myelofibrosis, leukaemia, anaemia, blood transfusion, malignant lymphomas, and bone marrow stem cell transplantation are some of the blood-related disorders. Hematology analyzers, also known as coagulation analyzers, are haematological equipment used to diagnose blood irregularities and illnesses. Hematology analyzers are fine-tuned instruments that determine the quantity of white blood cells, red blood cells and platelets in the body.

The rise in the prevalence of blood related diseases such as blood cancer and anemia is the significant factor responsible for driving the growth of the hematology analyzers and reagents market. Additionally, upsurge in the adoption rate of automated hematology Instruments and growing preferences high sensitivity point of care (POC) hematology testing towards will act as major drivers influencing the overall growth of the market. Similarly, factors such as swift technological advancement which include arrival of basic flow cytometry techniques and advancement of high throughput hematology analyzers will cushion the market growth rate.

Moreover, the increase in the expansion of various pharmaceutical and biotechnology industries especially in the developing economies and rising interest in the adoption of microfluidics technology will generate profitable opportunities for the hematology analyzers and reagents market.

However, the high cost involved in initial setup and strict regulations will act as market restraints and obstruct the market’s growth rate. Product recalls of defective hematology analyzers and reagents might further challenge the growth market.

This North America hematology analyzers and reagents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America hematology analyzers and reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Hematology Analyzers and Reagents Market Scope and Market Size

North America hematology analyzers and reagents market is segmented on the basis of product and services, price range, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product and services, the hematology analyzers and reagents market is segmented into hematology products and services, haemostasis products and services, immunohematology products and services, plasma protein analyser, haemoglobin analysers, erythrocyte sedimentation rate analysers, coagulation analyser, flow cytometers and differential counters. Hematology products and services are further sub-segmented into instruments, reagents and consumables and services. Instruments are divided into 5-part and 6-part fully automated hematology analyzers, 3-part fully automated hematology analyzers, point-of-care testing hematology analyzers, semi-automated hematology analyzers and highly complex clinical laboratory analyser. Reagents and consumables are divided into hematology reagents, controls and calibrators, slide strainers/makers, and consumables. Haemostasis products and services are further sub-segmented into instruments, reagents and consumables and services. Immunohematology products and services have been sub-segmented into instruments, reagents and consumables and services.
• On the basis of price range, the hematology analyzers and reagents market is segmented into high-end, mid-range and low-end.
• On the basis of application, the hematology analyzers and reagents market is segmented into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, immune system related conditions and others.
• On the basis of end user, the hematology analyzers and reagents market is segmented into hospital laboratories, blood banks, commercial service providers, government reference laboratories, research and academic institute and others.

North America Hematology Analyzers and Reagents Market Country Level Analysis

North America hematology analyzers and reagents market is analysed and market size insights and trends are provided by country, product and services, price range, application and end user as referenced above.

The countries covered in the North America hematology analyzers and reagents market report are U.S., Canada and Mexico.

The country section of the North America hematology analyzers and reagents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

North America hematology analyzers and reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America hematology analyzers and reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on North America hematology analyzers and reagents market. The data is available for historic period 2010 to 2019.

Competitive Landscape and North America Hematology Analyzers and Reagents Market Share Analysis

North America hematology analyzers and reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America hematology analyzers and reagents market.

The major players covered in the North America hematology analyzers and reagents market report are Johnson & Johnson Private Limited, Erba Diagnostics, Inc., Abbott, Siemens, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher, HORIBA, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., NIHON KOHDEN CORPORATION, Ortho Clinical Diagnostics, and Boule, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-1814